Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25076 | HC-7366 | 2803470-63-3 | ≧98.0% |  |
| HC-7366 is a potent and selective activator of the general control nonderepressible 2 | ||||
| 25036 | 1H-Indazole, 6-bromo-1,3-dimethyl- | 1095539-84-6 | 98% Min. |  |
| 25001 | HC-5404 | 2247396-91-2 | ≧98.0% |  |
| HC-5404 is a novel, highly selective and potent PERK inhibitor. | ||||
| 24145 | H2-Gamendazole | 877768-84-8 | 98% Min. |  |
| H2-Gamendazole is a derivative of Lonidamine that reduces cyst formation in polycysti | ||||
| 24115 | HTL14242 | 1644645-32-8 | 98% Min. |  |
| HTL14242 is a mGlu5 Negative Allosteric Modulator. Metabotropic glutamate receptors ( | ||||
| 24112 | HC-5404-FU | 3034479-99-4 | ≧98.0% |  |
| HC-5404-FU is a novel, highly selective and potent PERK inhibitor. | ||||
| 24077 | HH-0043 | 2922069-42-7 | 98% Min. |  |
| 20661 | HFY-4A | 2094810-82-7 | 98% Min. |  |
| HFY-4A is a HDAC inhibitor. HFY-4A inhibits breast cancer cell proliferation, migrati | ||||
| 20658 | Hynic-TOC | 257943-19-4 | 98% Min. |  |
| Hynic-TOC is a ligand for making 99mTc-Hynic-TOC as an imaging agent in the diagnosti | ||||
| 20568 | HDAC-IN-58 | 2071224-39-8 | 98% Min. |  |
| HDAC-IN-58 is a HDAC inhibitor. | ||||
| 20521 | 1H-1,2,3-triazole, 4,5-diiodo- | 28194-09-4 | 98% Min. |  |
| 20517 | HM43239 | 2569527-64-4 | 98% Min. |  |
| HM43239 is an orally active small molecule inhibitor of FLT3 that selectively inhibit | ||||
| 20482 | 4(3H)-Pyrimidinone, 5-bromo-6-cyclopropyl- | 27192-20-7 | 98% Min. |  |
| 20430 | 2(1H)-Pyridinone, 5,6-dihydro-4-(4-methylphenyl)-3-(2H-tetrazol-5-yl)-6-[4-(4,4,4-trifluorobutoxy)phenyl]-6-(trifluoromethyl)-, (6S)- | 1441057-15-3 | 98% Min. | -Pyridinone,_5,6-dihydro-4-(4-methylphenyl)-3-(2H-tetrazol-5-yl)-6-[4-(4,4,4-trifluorobutoxy)phenyl]-6-(trifluoromethyl)-,_(6S)-_1441057-15-3.png) |
| 20422 | 1H-Indazole-1-acetic acid, 3-acetyl-5-bromo-, 1,1-dimethylethyl ester | 2086183-72-2 | 98% Min. |  |
| 20410 | 1H-Pyrrolo[2,3-b]pyridine, 4-chloro-1-[tris(1-methylethyl)silyl]- | 651744-48-8 | 98% Min. | silyl]-_651744-48-8.png) |
| 20404 | 4-hydroxybiphenyl-4-carboxamide | 182318-78-1 | 98% Min. |  |
| 20388 | 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, ethyl ester | 221675-35-0 | 98% Min. |  |
| 20371 | 6-Hydroxyl-2-tetralone | 52727-28-3 | 98% Min. |  |
| 210201 | HISPOLON(P) | 173933-40-9 | 98% Min. | _173933-40-9.png) |
| 2091910 | 5-Hydroxymethyldeoxyuridine | 5116-24-5 | 98% Min. |  |
| 5-Hydroxymethyldeoxyuridine is a nucleoside analog with anticancer and antiviral acti | ||||
| 2091204 | 5-hydroxy-2,4-dimethylpyrimidine | 412003-95-3 | ≧96.0% | _412003-95-3.png) |
| 2,4-dimethylpyrimidin-5-ol is a key intermidiate ofLemborexant. Kg scale may be provi | ||||
| 2071633 | H-BETA-ALA-AMC TFA | 201847-54-3 | 98% Min. | |
| 206104 | HC-070 | 1628291-95-1 | 98% Min. |  |
| HC-070 is a potent inhibitor of TRPC4 and TRPC5, leading to anxiolytic and antidepres | ||||
| 204610 | Hydroxyfasudil HCl | 155558-32-0 (HCl) | 98% Min. | .gif) |
| Hydroxyfasudil, aslo known as HA1100, is a cell-permeable hydroxylated metabolite of | ||||
| 19317 | HBX-41108 | 924296-39-9 | >98% |  |
| HBX 41108 is an inhibitor of ubiquitin-specific protease (USP) 7. HBX 41108 inhibits | ||||
| 192223 | HS-1371 | 2158197-70-5 | >98% |  |
| HS-1371 is a novel kinase inhibitor of RIP3-mediated necroptosis. HS-1371 directly bi | ||||
| 19182 | HZ-1157 | 1009734-33-1 | >98% |  |
| HZ-1157 is a hepatitis C virus (HCV) inhibitor with inhibitory activities toward HCV | ||||
| 1811022 | H 151 | 941987-60-6 | >98% |  |
| H 151 is a STING antagonist that covalently binds STING at Cys91, blocking palmitoyla | ||||
| 1810171 | HC-056456 | 7733-96-2 | >98% |  |
| HC-056456 is a CatSper channel modulator. | ||||